Initial antiretroviral therapy in chronically-infected HIV-positive adults

Zelalem Temesgen, Francesca Cainelli, David Warnke, Janak Koirala

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations


Currently, there are 20 individual antiretroviral drugs and two co-formulation products that are approved by the FDA for the treatment of HIV-infected individuals. It is widely accepted that the selection of an appropriate first-line regimen is critical in assuring durable treatment response. This article reviews the factors that should be considered in the selection of an initial antiretroviral regimen and present the currently available evidence regarding the status of individual antiretroviral agents and treatment strategies relative to these factors. 2004

Original languageEnglish (US)
Pages (from-to)595-612
Number of pages18
JournalExpert Opinion on Pharmacotherapy
Issue number3
StatePublished - Mar 2004


  • Antiretroviral drugs
  • Antiretroviral therapy
  • Highly active antiretroviral therapy (HAART)
  • Initial antiretroviral regimen

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)


Dive into the research topics of 'Initial antiretroviral therapy in chronically-infected HIV-positive adults'. Together they form a unique fingerprint.

Cite this